LEADER 01591nam  2200541Ia 450 
001 9910779519103321
005 20230721010742.0
010   $a1-60876-737-X
035   $a(CKB)2550000001041341
035   $a(EBL)3018469
035   $a(SSID)ssj0000834897
035   $a(PQKBManifestationID)11412035
035   $a(PQKBTitleCode)TC0000834897
035   $a(PQKBWorkID)10982060
035   $a(PQKB)10495806
035   $a(MiAaPQ)EBC3018469
035   $a(Au-PeEL)EBL3018469
035   $a(CaPaEBR)ebr10660330
035   $a(OCoLC)923658476
035   $a(EXLCZ)992550000001041341
100   $a20091106d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aApoprotein research$b[electronic resource] /$fLinda R. Penfield and Rachel T. Nelson, editors
210   $aNew York $cNova Biomedical Books$dc2009
215   $a1 online resource (323 p.)
300   $aDescription based upon print version of record.
311   $a1-60692-632-2 
320   $aIncludes bibliographical references and index.
606   $aApolipoproteins
606   $aBlood proteins
606   $aRecombinant proteins
615  0$aApolipoproteins.
615  0$aBlood proteins.
615  0$aRecombinant proteins.
676   $a612.015756
701   $aPenfield$b Linda R$01523775
701   $aNelson$b Rachel T$01523776
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910779519103321
996   $aApoprotein research$93764119
997   $aUNINA